All these results suggest that the relationship between MALAT1 expression and shorter TTT that we have observed in PB samples could represent a surrogate biomarker for the degree of stimulation and proliferation of CLL cells in the LN. This evidence concerns the gene MALAT1 and B-cell chronic lymphocytic leukemia.